LiT Biosciences Launches LiT Protect Wellness Supplement
SPOKANE, Wash., May 7, 2026 LiT Biosciences, LLC announced the launch of LiT Protect, a patent-pending botanical dietary supplement...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
SPOKANE, Wash., May 7, 2026 LiT Biosciences, LLC announced the launch of LiT Protect, a patent-pending botanical dietary supplement...
